- Report
- October 2025
- 98 Pages
South Korea
From €4316EUR$4,850USD£3,748GBP
- Report
- October 2025
- 85 Pages
Qatar
From €4316EUR$4,850USD£3,748GBP
- Report
- October 2025
- 97 Pages
United Kingdom
From €4316EUR$4,850USD£3,748GBP
- Report
- September 2025
- 99 Pages
Nigeria
From €4316EUR$4,850USD£3,748GBP
- Report
- September 2025
- 80 Pages
United Kingdom
From €4316EUR$4,850USD£3,748GBP
- Report
- September 2025
- 82 Pages
Germany
From €4316EUR$4,850USD£3,748GBP
- Report
- September 2025
- 96 Pages
Philippines
From €4316EUR$4,850USD£3,748GBP
- Report
- September 2025
- 91 Pages
Poland
From €4316EUR$4,850USD£3,748GBP
- Report
- September 2025
- 87 Pages
Egypt
From €4316EUR$4,850USD£3,748GBP
- Report
- September 2025
- 84 Pages
Turkey
From €4316EUR$4,850USD£3,748GBP
- Report
- September 2025
- 96 Pages
Germany
From €4316EUR$4,850USD£3,748GBP
- Report
- June 2025
- 300 Pages
Global
From €2647EUR$2,975USD£2,299GBP
€3782EUR$4,250USD£3,284GBP
- Report
- May 2025
- 80 Pages
From €2625EUR$2,950USD£2,279GBP
- Report
- April 2025
- 80 Pages
Vietnam
From €4316EUR$4,850USD£3,748GBP
- Report
- March 2025
- 219 Pages
China
From €3559EUR$4,000USD£3,091GBP
- Report
- March 2025
- 92 Pages
China
From €1602EUR$1,800USD£1,391GBP
- Report
- January 2025
- 230 Pages
United States
From €3114EUR$3,500USD£2,704GBP
- Training
- December 2024
- 3 Days
Global
From €2074EUR$2,331USD£1,801GBP
- Report
- November 2024
- 750 Pages
Global
From €1780EUR$2,000USD£1,545GBP
- Report
- October 2024
- 80 Pages
Vietnam
From €3203EUR$3,600USD£2,782GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more